JAY JEFFREY R
Q2 2013 Form 13-F
CIK 0001239607
· Institutional investment manager
Holdings reported by
GREAT POINT PARTNERS LLC since Q3 2013
$126.5M Reported Value Total
Reported value
$126.5M
Quarter over quarter
-4.3%
Holdings
29
Top-10 concentration
72.3%
Filing Structure
Reports holdings for
- GREAT POINT PARTNERS LLC · File #028-11743 · Q2 2013 – Q2 2013 · declared by one filing
- KROIN DAVID (not a 13F filer in our records) · File #028-13262 · Q2 2013 – Q2 2013
Holdings reported by
- GREAT POINT PARTNERS LLC · since Q3 2013
Key People
Named on the latest Form 13-F filing — not necessarily an owner
M.d. Dr. Jeffrey R. Jay
Senior Managing Member
Filing Navigation
13F Metrics
Loading 13F Metrics
Q2 2013 13F record
Q2 2013 13F filing summary
| Period of report | June 30, 2013 |
|---|---|
| Filed | August 14, 2013 |
| Form | 13F-HR |
| Reported value | $126.5M |
| Positions | 29 |
| Change in reported value | +35.6% |
| New positions | 16 |
| Exited positions | 5 |
| Position turnover | 61.8% |
| Top-10 concentration | 72.3% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q2 2013 13F
Filed Aug 14, 2013
|
29 | $126.5M |
Top 20 holdings · Q2 2013
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | HPTX HYPERION THERAPEUTICS INC. | $21.2M | 16.76% |
| 2 | FURX FURIEX PHARMACEUTICAL, INC. | $16.8M | 13.3% |
| 3 | STML STEMLINE THERAPEUTICS INC. | $14.2M | 11.22% |
| 4 | BIOD BIODEL INC. | $7.7M | 6.12% |
| 5 | AMBI AMBIT BIOSCIENCES CORP | $7.0M | 5.53% |
| 6 | GERN GERON CORPORATION | $5.6M | 4.45% |
| 7 | PTIE PAIN THERAPEUTICS INC. | $5.1M | 4.06% |
| 8 | SSH SUNSHINE HEART INC. | $5.1M | 4.03% |
| 9 | DRTX DURATA THERAPEUTICS INC. | $4.6M | 3.64% |
| 10 | NDZ NORDION INC. | $4.0M | 3.14% |
| 11 | HZNP HORIZON PHARMA, INC. | $3.9M | 3.1% |
| 12 | OGXI ONCOGENEX PHARMACEUTICAL INC. | $3.4M | 2.69% |
| 13 | IPXL P IMPAX LABORATORIES, INC. | $3.0M | 2.36% |
| 14 | TRIB TRINITY BIOTECH PLC | $2.7M | 2.17% |
| 15 | RTIX RTI BIOLOGICS, INC. | $2.5M | 2.0% |
| 16 | DYAX DYAX CORP | $2.5M | 1.99% |
| 17 | MSTX MAST THERAPEUTICS INC. | $2.5M | 1.97% |
| 18 | PLX PROTALIX BIOTHERAPEUTICS INC. | $2.0M | 1.55% |
| 19 | MYGN P MYRIAD GENETICS INC. | $1.9M | 1.49% |
| 20 | VOLC VOLCANO CORPORATION | $1.8M | 1.43% |
Values as reported on the Q2 2013 Form 13F. Every position is in the holdings table below.